The Pittsburgh NMR Center, jointly sponsored by Carnegie Mellon University and the University of Pittsburgh is funded as a Biomedical Technology Research Center by the National Institute of Biomedical Imaging and Bioengineering and the National Institutes of Health
Preventing Seizure Progression - Carnegie Mellow University researchers have identified a new anticonvulsant compount that has the potential to stop the development of epilepsy. Findings are published in the journal Epilepsia.